OPKO Health, Inc. Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2026-06-30 was 546.07K shares, a 41.98% increase year-over-year.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was 384.61K shares, a 0.06% increase year-over-year.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2025-03-31 was 56.25K shares.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2024-12-31 was 0.00 shares.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2025 was 636.83K shares, a 65.68% increase from fiscal 2024.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2024 was 384.38K shares, a 5.26% decline from fiscal 2023.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2023 was 405.72K shares, a 69.18% decline from fiscal 2022.
- OPKO Health, Inc. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2022 was 1.32M shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | 546.07K shares 10-Q/A · filed 2026-08-28 | |
| 2025-12-31 | 636.83K shares 10-K · filed 2026-02-26 | |
| 2025-06-30 | 384.61K shares 10-Q/A · filed 2026-08-28 | 440.86K shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | 56.25K shares 10-Q/A · filed 2026-08-28 | 440.63K shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 384.38K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-10-29 | 384.38K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 384.38K shares 10-Q · filed 2025-07-31 | 403.13K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-01 | 405.72K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 405.72K shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 18.75K shares 10-Q · filed 2024-11-07 | 370.65K shares derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 386.97K shares 10-Q · filed 2024-08-07 | 1.10M shares derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | |
| 2022-12-31 | -35.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 1.32M shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 749.55K shares 10-Q · filed 2023-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |